What is the treatment for Fifth disease (erythema infectiosum)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Fifth Disease (Erythema Infectiosum)

Fifth disease (erythema infectiosum) requires only symptomatic and supportive treatment as it is typically a self-limiting condition that resolves spontaneously within three weeks without sequelae. 1

Disease Overview

  • Fifth disease is a common exanthematous illness of childhood caused by human parvovirus B19 that spreads primarily through respiratory tract secretions 1
  • The condition most commonly affects children between 4 and 10 years of age, with an incubation period of 4 to 14 days 1
  • The characteristic rash evolves in three stages:
    1. Initial "slapped cheek" appearance on the face
    2. Spread to trunk and extremities with a lacy or reticulated appearance
    3. Evanescence and recrudescence phase 1

Recommended Treatment Approach

Symptomatic Management

  • Antipyretics for low-grade fever (acetaminophen or ibuprofen) 1
  • Rest and adequate hydration for general malaise and fatigue 1
  • Antihistamines may be considered for pruritus, which occurs in approximately 50% of cases 1

Special Considerations

Arthritis/Arthralgia

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) for joint pain and inflammation, which is more common in adults than children 1, 2

Immunocompromised Patients

  • Patients with chronic hemolytic anemias may develop transient aplastic crisis requiring close monitoring and possibly transfusion 1, 2
  • Immunocompromised patients may develop chronic anemia requiring specialized care 2

Pregnant Women

  • Pregnant women exposed to fifth disease should be evaluated for immune status:
    • If IgG positive (already immune), there is no risk to the fetus
    • If not immune, fetal surveillance with repeated ultrasonographic examinations is recommended due to risk of fetal hydrops, although this risk is very low 3

Important Clinical Pearls

  • No specific antiviral treatment exists for parvovirus B19 infection 1
  • Antibiotics are not indicated as this is a viral illness 1
  • The diagnosis is primarily clinical and laboratory confirmation is usually unnecessary in typical cases 1
  • The rash in adults may be less pronounced and often atypical compared to children 1
  • Conjunctivitis may occasionally be present and requires only supportive care 4

Complications to Monitor

  • Transient aplastic crisis in patients with underlying hemolytic disorders 1, 2
  • Arthropathy, particularly in adult women 2
  • Fetal hydrops in pregnant women (rare) 3

The self-limiting nature of fifth disease in immunocompetent individuals means that treatment focuses on symptom relief rather than attempting to alter the course of the infection 1, 2.

References

Research

Erythema Infectiosum: A Narrative Review.

Current pediatric reviews, 2024

Research

Fifth (human parvovirus) and sixth (herpesvirus 6) diseases.

Current opinion in infectious diseases, 2001

Research

Erythema infectiosum (Fifth disease) and pregnancy.

Canadian family physician Medecin de famille canadien, 1999

Research

Conjunctivitis associated with fifth disease in a child: a case report.

Journal of the American Optometric Association, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.